Search Within

Department of Medicine

Formats
  1. Journal Article (19627)
  2. Meeting Abstract (16084)
  3. Review (1160)
  4. Book Section (934)
  5. Editorial (612)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (237)
  10. Miscellaneous (91)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22376)
  2. Hematologic Malignancies, Division of (13310)
  3. Center for Hematologic Malignancies (11084)
  4. GSK Faculty (10660)
  5. Survivorship Research (9357)
  6. Division of Subspecialty Medicine (7562)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1168)
  2. 2024 (2293)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1411)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (904)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4217)
  3. American Society of Hematology (4004)
  4. American Association for Cancer Research (2898)
  5. Oxford University Press (2306)
  6. Nature Publishing Group (2123)

More Publishers

Results (39721)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Ocular findings in patients with histiocytosis
    Meeting Abstract

    Francis, J. H.; Reiner, A. S.; Canestraro, J.; Raajit, R.; Abramson, D. H.; Diamond, E. L.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy of alpelisib in PI3K-driven langerhans cell histiocytosis
    Meeting Abstract

    Mazor, R. D.; Durham, B. H.; Abdel-Wahab, O. I.; Diamond, E. L.; Yabe, M.; Itchaki, G.; Ben-Sasson, M.; Hershkovitz-Rokah, O.; Shpilberg, O.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Polyethnic-1000: A New York-based initiative to advance cancer genomics through recruitment of diverse racial & ethnic populations
    Meeting Abstract

    Balogun, O.; Davis, M.; Mehallow, M.; Robine, N.; Winterkorn, L.; Oschwald, D.; Zody, M.; Aparicio, S.; Maniatis, T.; Varmus, H.; more...
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplant cyclophosphamide improves clinical outcomes for racial and ethnic minority patients with hematologic malignancies
    Meeting Abstract

    Jimenez, A. M. J.; Iyer, S.; Komanduri, K.; Brown, S.; Wang, T.; Chinapen, S.; Pereira, D.; Devlin, S.; Goodman, M.; Beitinjaneh, A.; more...
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save
  • Exercise associated with cognitive function in older men with prostate cancer undergoing androgen deprivation therapy
    Journal Article

    Gaynor, A. M.; Flaherty, K. R.; Root, J. C.; Salas-Ramirez, K. Y.; Scott, J. M.; Nelson, C. J.
    International Journal of Behavioral Medicine (2023)

    Fulltext@MSK | Save
  • Rucaparib or physician's choice in metastatic prostate cancer
    Journal Article

    Fizazi, K.; Piulats, J. M.; Reaume, M. N.; Ostler, P.; MeDermott, R.; Gingerich, J. R.; Pintus, E.; Sridhar, S. S.; Bambury, R. M.; Emmenegger, U.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): Extended follow-up from the phase 3, randomised, open-label study
    Journal Article

    Choueiri, T. K.; Eto, M.; Motzer, R.; De Giorgi, U.; Buchler, T.; Basappa, N. S.; Méndez-Vidal, M. J.; Tjulandin, S.; Park, S. H.; Melichar, B.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: Final 10-year analysis of the open-label, single-arm, phase 2 APT trial
    Journal Article

    Tolaney, S. M.; Tarantino, P.; Graham, N.; Tayob, N.; Parè, L.; Villacampa, G.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save